Zhongzhi Pharmaceutical Holdings Limited
HKEX:3737.HK
0.9 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 164.368 | 381.01 | 233.381 | 294.032 | 380.333 | 332.698 | 359.458 | 326.135 | 426.637 | 58.004 | 29.077 |
| Short Term Investments
| 2.277 | 14.687 | 15.669 | 16.427 | 7.862 | 7.67 | 9.167 | 4.077 | 3.736 | 3.062 | 27.229 |
| Cash and Short Term Investments
| 166.645 | 395.697 | 257.845 | 311.039 | 388.195 | 340.368 | 368.625 | 330.212 | 430.373 | 61.066 | 56.306 |
| Net Receivables
| 327.986 | 311.561 | 293.559 | 283.088 | 242.764 | 162.033 | 118.318 | 63.863 | 56.446 | 35.489 | 28.804 |
| Inventory
| 330.017 | 322.901 | 268.057 | 247.121 | 199.039 | 178.992 | 137.924 | 121.081 | 99.894 | 88.471 | 108.94 |
| Other Current Assets
| 26.091 | 75.448 | 46.771 | 43.216 | 8.561 | 15.239 | 33.691 | 17.087 | 9.307 | 5.351 | 5.989 |
| Total Current Assets
| 874.121 | 1,090.92 | 857.437 | 883.884 | 838.559 | 696.632 | 658.558 | 532.243 | 596.02 | 190.377 | 200.039 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 675.994 | 573.603 | 547.311 | 431.995 | 388.898 | 256.464 | 203.198 | 180.053 | 89.133 | 79.366 | 71.406 |
| Goodwill
| 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 | 1.628 |
| Intangible Assets
| 14.218 | 15.398 | 18.29 | 19.56 | 18.559 | 8.877 | 10.413 | 1.709 | 1.808 | 1.366 | 1.573 |
| Goodwill and Intangible Assets
| 15.846 | 17.026 | 19.918 | 21.188 | 20.187 | 10.505 | 12.041 | 3.337 | 3.436 | 2.994 | 3.201 |
| Long Term Investments
| 49.314 | 17.914 | 17.001 | 24.809 | 16.78 | 18.176 | 13.842 | 9.08 | 7.65 | 77.384 | 0 |
| Tax Assets
| 30.069 | 30.189 | 31.969 | 16.208 | 13.377 | 11.199 | 7.681 | 5.758 | 5.756 | 4.976 | 0 |
| Other Non-Current Assets
| 147.291 | -30.189 | -31.969 | -16.208 | -13.377 | -11.199 | -7.681 | -5.758 | -5.756 | -82.36 | 24.228 |
| Total Non-Current Assets
| 918.514 | 608.543 | 584.23 | 477.992 | 425.865 | 285.145 | 229.081 | 192.47 | 100.219 | 82.36 | 98.835 |
| Total Assets
| 1,792.635 | 1,875.257 | 1,524.105 | 1,420.521 | 1,280.539 | 1,011.486 | 911.952 | 755.228 | 723.528 | 297.924 | 298.874 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 170.725 | 189.779 | 120.828 | 110.439 | 104.3 | 85.418 | 71.623 | 57.531 | 53.576 | 52.802 | 54.218 |
| Short Term Debt
| 125.786 | 76.239 | 95.117 | 114.687 | 63.539 | 23.405 | 19.804 | 0 | 0 | 15 | 24.814 |
| Tax Payables
| 49.218 | 64.697 | 47.334 | 42.066 | 39.254 | 25.07 | 22.038 | 15.589 | 10.167 | 20.219 | 0 |
| Deferred Revenue
| -78.212 | -76.239 | -95.117 | -114.687 | -63.539 | -23.405 | -19.804 | 0 | 0 | -15 | 0 |
| Other Current Liabilities
| 390.309 | 541.472 | 380.003 | 375.031 | 317.849 | 198.081 | 158.959 | 112.78 | 91.534 | 110.829 | 78.734 |
| Total Current Liabilities
| 608.608 | 731.251 | 500.831 | 485.47 | 422.149 | 283.499 | 230.582 | 170.311 | 145.11 | 163.631 | 157.766 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 99.275 | 94.621 | 80.624 | 73.216 | 63.966 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.866 | 15.842 | 15.429 | 14.215 | 17.768 | 20.004 | 11.628 | 14.693 | 13.72 | 9.047 | 0 |
| Deferred Tax Liabilities Non-Current
| 19.553 | 27.594 | 26.056 | 25.857 | 13.273 | 1.391 | 1.467 | 1.843 | 2.01 | 4.349 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 130.694 | 138.057 | 122.109 | 113.288 | 95.007 | 21.395 | 13.095 | 16.536 | 15.73 | 13.396 | 0 |
| Total Liabilities
| 739.302 | 869.308 | 622.94 | 598.758 | 517.156 | 304.894 | 243.677 | 186.847 | 160.84 | 177.027 | 157.766 |
| Equity: | |||||||||||
| Preferred Stock
| 110.743 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 6.847 | 6.847 | 6.847 | 6.65 | 6.65 | 6.65 | 6.65 | 6.309 | 6.309 | 0 | 0 |
| Retained Earnings
| 816.538 | 764.506 | 658.119 | 605.991 | 467.459 | 352.765 | 258.484 | 188.428 | 134.556 | 84.017 | 93.329 |
| Accumulated Other Comprehensive Income/Loss
| 27.662 | 28.752 | 30.903 | 34.505 | 45.834 | 42.914 | 40.127 | 42.868 | 56.826 | 36.88 | 36.881 |
| Other Total Stockholders Equity
| 86.726 | 202.871 | 202.871 | 173.03 | 243.44 | 304.263 | 363.014 | 330.776 | 364.997 | 0 | 0 |
| Total Shareholders Equity
| 1,048.516 | 1,002.976 | 898.74 | 820.176 | 763.383 | 706.592 | 668.275 | 568.381 | 562.688 | 120.897 | 130.21 |
| Total Equity
| 1,053.333 | 1,005.949 | 901.165 | 821.763 | 763.383 | 706.592 | 668.275 | 568.381 | 562.688 | 120.897 | 130.21 |
| Total Liabilities & Shareholders Equity
| 1,792.635 | 1,875.257 | 1,524.105 | 1,420.521 | 1,280.539 | 1,011.486 | 911.952 | 755.228 | 723.528 | 297.924 | 298.874 |